Page last updated: 2024-09-05

sb 203580 and Teratoma

sb 203580 has been researched along with Teratoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernstein, HS; Boyle, A; Gaur, M; Prasad, M; Ritner, C; Sievers, RE; Yeghiazarians, Y; Zhang, Y	1

Other Studies

1 other study(ies) available for sb 203580 and Teratoma

Article	Year
Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition. Cytotherapy, 2012, Volume: 14, Issue:2 Topics: Animals; Apoptosis; Cell Differentiation; Disease Models, Animal; Embryonic Stem Cells; Enzyme Activation; Fibroblasts; Heart Ventricles; Humans; Imidazoles; Immunohistochemistry; Injections; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 14; Myocardial Infarction; Myocytes, Cardiac; Pyridines; Teratoma	2012

Article

Year

Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Cytotherapy, 2012, Volume: 14, Issue:2

Topics: Animals; Apoptosis; Cell Differentiation; Disease Models, Animal; Embryonic Stem Cells; Enzyme Activation; Fibroblasts; Heart Ventricles; Humans; Imidazoles; Immunohistochemistry; Injections; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 14; Myocardial Infarction; Myocytes, Cardiac; Pyridines; Teratoma

2012